Document Detail


Association of periprocedural neurological deficit in carotid stenting with increased anticardiolipin antibodies.
MedLine Citation:
PMID:  18817951     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: Carotid stenting (CS) has become a therapeutic alternative to endarterectomy in selected patients. Periinterventional plaque thromboembolism leading to neurological ischemic events remain the major risk of the procedure. We prospectively studied the potential role of thrombophilic conditions including anticardiolipin antibodies (ACA, IgG and IgM isotype), lupus anticoagulants, activated protein C resistance, antithrombin, and protein C and S. MATERIAL AND METHODS: The study was approved by the local ethics committee, and written informed consent was obtained from all patients. In total, 236 consecutive patients were included (158 men, 78 woman; median age 73 years). Prothrombotic markers were quantitated on the day of admission. Periprocedural neurological deficits (PND) occurring within 48 hours of the intervention were recorded and classified by an independent neurologist as transient ischemic attack, minor or major stroke. Uni- and multivariable logistic regression analysis were performed to test for the influence of thrombophilic conditions, demographic factors and lesion characteristics on PND. RESULTS: Neurologic complications occurred in 18 interventions (7.6%). In 4 (36.4%; 3 minor, 1major stroke) out of 11 patients with elevated IgG-ACA neurological events were observed as compared to 14 (6.2%; 6 TIA, 5 minor stroke, 3 major stroke) out of 225 patients with normal IgG-ACA levels. In multivariable analysis, two variables were independently associated with PND: elevated IgG-ACA (OR 6.09, 95% CI 1.49-25.88; P=0.012) and lesion length >10 mm (OR 4.36, 95% CI 1.19 to 16.01; P=0.027). CONCLUSIONS: A thrombophilic condition due to elevation of anticardiolipin antibodies increases the risk of periinterventional neurological complications during CS.
Authors:
Sabine Steiner; Roela Sadushi; Andrea Bartok; Alexandra Hammer; Peter Quehenberger; Christine Mannhalter; Renate Koppensteiner; Erich Minar; Christoph W Kopp
Publication Detail:
Type:  Journal Article     Date:  2008-09-24
Journal Detail:
Title:  Thrombosis research     Volume:  123     ISSN:  0049-3848     ISO Abbreviation:  Thromb. Res.     Publication Date:  2009 Apr 
Date Detail:
Created Date:  2009-03-31     Completed Date:  2009-07-17     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0326377     Medline TA:  Thromb Res     Country:  United States    
Other Details:
Languages:  eng     Pagination:  827-31     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine II, Medical University Vienna, Austria. sabine.steiner-boeker@meduniwien.ac.at
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Activated Protein C Resistance / blood,  complications
Aged
Aged, 80 and over
Antibodies, Anticardiolipin / blood*
Antithrombins / metabolism
Carotid Stenosis / blood,  immunology*,  therapy*
Female
Humans
Immunoglobulin G / blood
Ischemic Attack, Transient / blood,  etiology,  immunology
Lupus Coagulation Inhibitor / blood
Male
Middle Aged
Multivariate Analysis
Nervous System Diseases / blood,  etiology*,  immunology*
Prospective Studies
Protein C / metabolism
Protein S / metabolism
Risk Factors
Stents / adverse effects*
Stroke / blood,  etiology,  immunology
Thrombophilia / blood,  complications
Chemical
Reg. No./Substance:
0/Antibodies, Anticardiolipin; 0/Antithrombins; 0/Immunoglobulin G; 0/Lupus Coagulation Inhibitor; 0/Protein C; 0/Protein S

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Sulphur leaching from headwater catchments in an eroded peatland, South Pennines, U.K.
Next Document:  Determining the course of the dorsal nerve of the clitoris.